Oct. 29, 2002 (New Orleans) - Adding angiotensin II receptor blockers (ARBs) to conventional therapy for lupus nephritis significantly reduces proteinuria, according to a report presented here Sunday ...

Patients with intermediate-onset lupus nephritis were associated with poorer renal outcomes compared against those with early-onset disease. Patients who develop lupus nephritis (LN) within 1 to 5 ...

In a small observational study, telitacicept use was associated with improvement in renal and hematologic parameters in patients with lupus nephritis and nephrotic syndrome. Telitacicept use is ...

Many drugs, both old and new, are now being studied in people with lupus. The drugs described below are not a complete list of all the drugs currently in development for lupus, and they may not all ...

Researchers have developed a novel animal model that fundamentally changes the understanding of lupus, a complex autoimmune disease. They demonstrate for the first time that a defect in skin cells can ...